Author

R. Ladwa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Causer· 1 shared A. M. Kane· 1 shared B. A. Leggett· 1 shared B. Panizza· 1 shared B. Salik· 1 shared C. E. Bond· 1 shared C. Perry· 1 shared C. Su· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Causer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 10, 2023

Deep spatial-omics to aid personalization of precision medicine in metastatic recurrent Head & Neck Cancers

A. Causer, X. Tan, X. Lu…·J. L. Gonzalez Cruz

This study uses spatial-omics to identify tumor metabolic states and immune cell profiles in OPSCC, leading to insights on ICI failure and potential drug targets.

DOI 10.1101/2023.02.10.527955

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 11, 2022

Aspirin synergizes with regorafenib to reduce growth of colorectal cancer

C. Su, L. J. Fennell, C. E. Bond…·V. L. Whitehall

This study shows that aspirin and regorafenib together reduce colorectal cancer growth in preclinical models by inhibiting the PI3K-Akt-mTOR pathway and activating AMPK.

DOI 10.1101/2022.02.11.480021

humanbulk RNA-seq

𝕏 PostBluesky